This is a prospective multi-center study. All clinically stable, symptomatic patients who present to the emergency department (ED) or observation unit with suspected coronary artery disease (CAD) and who have at least one ≥40% lesion and no lesion \>90% confirmed by CCTA (Coronary Computed Tomography Angiogram) are eligible for enrollment once their CCTA has been completed and their FFR-CT (if applicable) has been ordered. All enrolling sites will have CCTA incorporated into their standard evaluation of chest pain in the ED/observation unit. Non-control sites will have CCTA and FFR-CT analysis incorporated into their standard evaluation of chest pain in the ED/observation unit.
This is a prospective multi-center study. All clinically stable, symptomatic patients who present to the ED or observation unit with suspected CAD and who have at least one ≥40% lesion and no lesions \<90% lesion in a major vessel, confirmed by CCTA, are eligible for enrollment once their CCTA has been completed and FFR-CT (if applicable) has been ordered. All enrolling sites will have CCTA incorporated into their standard evaluation of chest pain in the ED/observation unit. Non-control sites will have CCTA and FFR-CT analysis incorporated into their standard evaluation of chest pain in the ED/observation unit. All participating sites will provide demographics, medical history, CCTA images, FFR-CT (for non-control sites), the decision plan post CCTA and pre FFR-CT (for non-control sites), length of stay for patients in the ED/observation unit/hospital, billing reports (UB-04 preferred), 30-day clinical outcomes, and any other hospital or office visits, imaging, and/or procedural data completed prior to the follow-up 30-day visit. Sites which do not have FFR-CT incorporated into the ED/observation unit will be control sites.
Study Type
OBSERVATIONAL
Enrollment
13
FFRCT is a diagnostic test following a CCTA to help diagnose and treat coronary artery disease.
UMass Memorial Hospital
Worcester, Massachusetts, United States
University Hospital Clevelan
Cleveland, Ohio, United States
Reclassification rate between the coronary management plan based on the review of the CCTA alone compared to the coronary management plan based on the review of the CCTA and the FFR-CT analysis.
Time frame: 30 days
Cost Utility Analysis
Cost measurements to include length of stay in the emergency department and in the hospital overall, secondary coronary artery disease testing, and invasive procedures done.
Time frame: 30 days
Rate of Major Adverse Coronary Events (MACE)
Time frame: 30 days
Time to primary diagnosis
Time between when the patient first arrives to the emergency department to when the treating physician documents the primary diagnosis.
Time frame: Within 30 days
Time to discharge
Time between when the patient first arrives to the emergency department to the time the patient was discharged from the emergency department or the hospital.
Time frame: Within 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.